Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2
- PMID: 10395669
Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2
Abstract
The human IFN-alpha receptor (hIFNAR) is a complex composed of at least two chains, hIFNAR1 and hIFNAR2. We have performed a structure-function analysis of hIFNAR2 extracellular domain regions using anti-hIFNAR2 mAbs (1D3, 1F3, and 3B7) and several type I human IFNs. These mAbs block receptor activation, as determined by IFN-stimulated gene factor 3 formation, and block the antiviral cytopathic effects induced by type I IFNs. We generated alanine substitution mutants of hIFNAR2-IgG and determined that regions of hIFNAR2 are important for the binding of these blocking mAbs and hIFN-alpha2/alpha1. We further demonstrated that residues E78, W101, I104, and D105 are crucial for the binding of hIFN-alpha2/alpha1 and form a defined protrusion when these residues are mapped upon a structural model of hIFNAR2. To confirm that residues important for ligand binding are indeed important for IFN signal transduction, we determined the ability of mouse L929 cells expressing hIFNAR2 extracellular domain mutants to mediate hIFN signal. hIFN-alpha8, previously shown to signal a response in L929 cells expressing hIFNAR1, was unable to signal in L929 cells expressing hIFNAR2. Transfected cells expressing hIFNAR2 containing mutations at residues E78, W101, I104, or D105 were unresponsive to hIFN-alpha2, but remained responsive to hIFN-beta. In summary, we have identified specific residues of hIFNAR2 important for the binding to hIFN-alpha2/1 and demonstrate that specific regions of the IFNAR interact with the subspecies of type I IFN in different manners.
Similar articles
-
Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.J Immunol. 1998 Feb 15;160(4):1782-8. J Immunol. 1998. PMID: 9469437
-
Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.Biochemistry. 2004 Oct 5;43(39):12498-512. doi: 10.1021/bi049111r. Biochemistry. 2004. PMID: 15449939
-
Domains of interaction between alpha interferon and its receptor components.J Mol Biol. 1994 Oct 21;243(2):245-57. doi: 10.1006/jmbi.1994.1651. J Mol Biol. 1994. PMID: 7932753
-
Human type I interferons: structure and function.Acta Virol. 1994 Dec;38(6):345-60. Acta Virol. 1994. PMID: 7793359 Review.
-
Type I interferons: ancient peptides with still under-discovered anti-cancer properties.Protein Pept Lett. 2013 Apr;20(4):412-23. Protein Pept Lett. 2013. PMID: 23016588 Review.
Cited by
-
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13231-6. doi: 10.1073/pnas.221290398. Proc Natl Acad Sci U S A. 2001. PMID: 11698684 Free PMC article.
-
Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.Biochemistry. 2010 Jun 29;49(25):5117-33. doi: 10.1021/bi100041f. Biochemistry. 2010. PMID: 20496919 Free PMC article.
-
NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.Biochemistry. 2010 Feb 2;49(4):687-95. doi: 10.1021/bi901313x. Biochemistry. 2010. PMID: 20047337 Free PMC article.
-
The role of macrophage IL-10/innate IFN interplay during virus-induced asthma.Rev Med Virol. 2015 Jan;25(1):33-49. doi: 10.1002/rmv.1817. Epub 2014 Nov 27. Rev Med Virol. 2015. PMID: 25430775 Free PMC article. Review.
-
Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab.J Biol Chem. 2015 Jun 12;290(24):14979-85. doi: 10.1074/jbc.M115.652156. Epub 2015 Apr 29. J Biol Chem. 2015. PMID: 25925951 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases